ALACHUA, FL--(Marketwire - June 25, 2008) - ONI BioPharma Inc., formerly Oragenics, Inc. (AMEX: ONI), a biopharmaceutical company, today announced it had received notice that the American Stock Exchange ("AMEX") has accepted the Company's Revised Plan of Compliance to regain compliance with the applicable listing standards by October 27, 2008.
